Blog Archives

PRESS RELEASE: Great Lakes NeuroTechnologies Secures $1.7 Million to Develop Continuous Dyskinesia Monitoring Technology for Parkinson’s Disease

VIEW PRESS RELEASE [PDF]  05 Mar 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that they are launching commercialization and clinical studies to validate a system for objective, continuous monitoring of dyskinesias associated with Parkinson’s disease. The

Tagged with: , , , , , , , , , , , , , , ,

Objective Measure of Upper Extremity Motor Impairment in Parkinsons Disease with Inertial Sensors

J. Hoffman, J. McNames Conf Proc IEEE Eng Med Biol Soc. 2011;2011:4378-81

Tagged with: , , , , ,